Valuation: UCB

Capitalization 34.58B 36.23B 32.63B 28.72B 51.38B 3,146B 56.9B 388B 144B 1,313B 136B 133B 5,486B P/E ratio 2024 *
63x
P/E ratio 2025 * 35.4x
Enterprise value 35.98B 37.71B 33.96B 29.89B 53.47B 3,275B 59.22B 403B 150B 1,367B 141B 139B 5,709B EV / Sales 2024 *
6.11x
EV / Sales 2025 * 5.12x
Free-Float
61.3%
Yield 2024 *
0.77%
Yield 2025 * 0.79%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.05%
1 week-3.75%
Current month-3.21%
1 month-3.80%
3 months+2.33%
6 months+21.07%
Current year-5.23%
More quotes
1 week
180.50
Extreme 180.5
191.90
1 month
180.50
Extreme 180.5
194.50
Current year
180.50
Extreme 180.5
198.95
1 year
93.50
Extreme 93.5
198.95
3 years
65.40
Extreme 65.4
198.95
5 years
60.18
Extreme 60.18
198.95
10 years
54.84
Extreme 54.84
198.95
More quotes
Manager TitleAgeSince
Chief Executive Officer 66 2014-12-31
Director of Finance/CFO 58 2020-06-30
Chief Tech/Sci/R&D Officer 66 2018-12-31
Director TitleAgeSince
Director/Board Member 54 2011-12-31
Director/Board Member 66 2014-12-31
Director/Board Member 55 2014-04-23
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.05%-3.75%+93.65%+114.45% 36.23B
+2.14%-2.41%-7.11%-4.76% 79.64B
+1.90%+17.90%+40.69%+56.37% 58.52B
-0.81%-3.66%-37.32%-34.79% 20.1B
-1.85%-5.48%+327.83%+820.50% 14.74B
+0.59%+3.10%+21.50%+3.82% 13.63B
-0.19%+0.55%+68.96%+122.33% 13.58B
+0.67%+2.13%-26.95%-28.18% 12.36B
+0.98%+2.67%+10.26%-43.17% 12.05B
-0.13%-1.56%+26.20%+67.20% 10.14B
Average +0.33%-1.56%+51.77%+107.38% 27.1B
Weighted average by Cap. +0.96%-2.09%+39.02%+73.74%
See all sector performances

Financials

2024 *2025 *
Net sales 5.89B 6.17B 5.56B 4.89B 8.75B 536B 9.69B 66.02B 24.48B 224B 23.13B 22.67B 934B 6.85B 7.17B 6.46B 5.69B 10.17B 623B 11.27B 76.75B 28.46B 260B 26.88B 26.35B 1,086B
Net income 629M 659M 594M 523M 935M 57.26B 1.04B 7.05B 2.62B 23.9B 2.47B 2.42B 99.83B 963M 1.01B 909M 800M 1.43B 87.6B 1.58B 10.79B 4B 36.56B 3.78B 3.71B 153B
Net Debt 1.41B 1.48B 1.33B 1.17B 2.09B 128B 2.32B 15.79B 5.85B 53.48B 5.53B 5.42B 223B 481M 504M 454M 399M 715M 43.75B 791M 5.39B 2B 18.26B 1.89B 1.85B 76.29B
More financial data * Estimated data
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Calendar
More about the company
Date Price Change Volume
25-02-18 181.80 -0.25% 26,535
25-02-17 182.25 +1.00% 147,453
25-02-14 180.45 -3.58% 235,170
25-02-13 187.15 -1.68% 181,614
25-02-12 190.35 +0.50% 128,193

Real-time Euronext Bruxelles, February 18, 2025 at 06:04 am

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
182.25EUR
Average target price
202.88EUR
Spread / Average Target
+11.32%
Consensus

Quarterly revenue - Rate of surprise